1. Major depressive disorder and medical illness: STAR*D outcomes

   • Prakash Masand
   • Meera Narasimhan

   Invited Commentary Pages: 165 - 166

2. Web alert

   • Paul Ballas

   News Pages: 167 - 168

3. The glycine site of NMDA receptors—A target for treatment of schizophrenia

   • Joachim F. Hallmayer

   Clinical Trials Report Pages: 171 - 173

4. Culture, ethnicity, and paranoia

   • P. Sen
   • A. N. Chowdhury

   OriginalPaper Pages: 174 - 178

5. The relationship between delusions and hallucinations

   • Brendan A. Maher

   OriginalPaper Pages: 179 - 183

6. Metacognitive control over false memories: A key determinant of delusional thinking

   • Steffen Moritz
   • Todd S. Woodward

   OriginalPaper Pages: 184 - 190

7. Delusions in the nonclinical population

   • Daniel Freeman

   OriginalPaper Pages: 191 - 204

8. Musical hallucinations

   • Stefan Evers

   OriginalPaper Pages: 205 - 210

9. Metabolic syndrome in patients with schizophrenia: CATIE results

   • Meera Narasimhan
   • Prakash Masand

   Clinical Trials Report Pages: 213 - 214

10. Consultation-liaison psychiatry: How far have we come?

    • Sherese Ali
    • Carrie Ernst
    • Gregory Fricchione

    OriginalPaper Pages: 215 - 222

11. Panic symptoms at the interface of body and mind

    • Eduardo A. Colón

    OriginalPaper Pages: 223 - 227

12. Anxiety in medically III patients

    • Rajnish Mago
    • John-Paul Gomez
    • Elisabeth J. S. Kunkel

    OriginalPaper Pages: 228 - 233

13. Treatment of depression in Parkinson’s disease

    • Matthew Menza
    • Roseanne DeFronzo Dobkin
    • Humberto Marin

    OriginalPaper Pages: 234 - 240

14. Management of psychiatric comorbidity in fibromyalgia

    • Lesley M. Arnold

    OriginalPaper Pages: 241 - 245

15. Psycho-oncology: Review and update

    • Kathryn M. Kash
    • Rajnish Mago
    • Elisabeth J. S. Kunkel

    OriginalPaper Pages: 246 - 252